114 published certificates of analysis
Every certificate we hold is published here in full and unaltered. Type a compound or the lot number printed on your vial. Each row links to the laboratory's PDF, issued by Bioviridian Inc., and to the verification code you can check on the laboratory's own site. If your lot is not listed, email support with the lot number and we will send the certificate.
| Compound | Size | Lot | Issued | Purity (RP-HPLC) | Content | Endotoxin | Certificate |
|---|---|---|---|---|---|---|---|
| 5-Amino-1MQ | 50 mg | 5AM1MQ50-0803 | Aug 17, 2026 | 99.87% | 50.98 mg | <0.05 EU/mL | PDF · COA7587 |
| Adamax | 10 mg | ADA10-0803 | Aug 17, 2026 | 99.78% | 10.39 mg | <0.05 EU/mL | PDF · COA7596 |
| AOD-9604 | 5 mg | AOD5-0803 | Aug 17, 2026 | 99.78% | 5.16 mg | <0.05 EU/mL | PDF · COA7615 |
| ARA-290 | 16 mg | ARA2901-0803 | Aug 17, 2026 | 99.72% | 10.86 mg | <0.05 EU/mL | PDF · COA7616 |
| BPC-157 | 5 mg | BP5-0803 | Aug 17, 2026 | 99.73% | 5.33 mg | <0.05 EU/mL | PDF · COA7609 |
| BPC-157 | 10 mg | BP10-0803 | Aug 17, 2026 | 99.71% | 10.44 mg | <0.05 EU/mL | PDF · COA7603 |
| BPC-157 | 15 mg | BP15-0803 | Aug 17, 2026 | 99.84% | 15.75 mg | <0.05 EU/mL | PDF · COA7581 |
| BPC-157 + TB-500 | 20 mg | BPCTB20-0803 | Aug 17, 2026 | 99.78% | 10.73, 10.94 mg | <0.05 EU/mL | PDF · COA7621 |
| CJC-1295 (no DAC) | 10 mg | CJC10-0803 | Aug 17, 2026 | 99.76% | 10.38 mg | <0.05 EU/mL | PDF · COA7601 |
| CJC-1295 (no DAC) + GHRP-6 | 5 mg / 5 mg | CJCGHRP5-0528 | Jun 17, 2026 | 99.9% | 5.23, 5.11 mg | <0.05 EU/mL | PDF · COA4860 |
| CJC-1295 + Ipamorelin | 5 mg / 5 mg | CJCIP10-0803 | Aug 17, 2026 | 99.80% | 5.13, 5.55 mg | <0.05 EU/mL | PDF · COA7607 |
| CJC-1295 + Ipamorelin | 10 mg | CJCIP10-0318 | Apr 3, 2026 | 99.8% | 5.76, 6.24 mg | ≤0.05 EU/mL | PDF · COA3378 |
| CJC-1295 + Ipamorelin | 10 mg / 10 mg | CJCIP20-0803 | Aug 17, 2026 | 99.82% | 10.62,10.55 mg | <0.05 EU/mL | PDF · COA7631 |
| DSIP | 5 mg | DSIP5-0803 | Aug 17, 2026 | 99.72% | 5.21 mg | <0.05 EU/mL | PDF · COA7602 |
| Epithalon | 10 mg | EPIT10-0803 | Aug 17, 2026 | 99.68% | 10.63 mg | <0.05 EU/mL | PDF · COA7622 |
| GHK-Cu | 50 mg | GHK50-0803 | Aug 17, 2026 | 99.77% | 51.02 mg | <0.05 EU/mL | PDF · COA7628 |
| GHK-Cu | 100 mg | GHK100-0803 | Aug 17, 2026 | 99.86% | 101.36 mg | <0.05 EU/mL | PDF · COA7578 |
| GLOW mix | 70 mg | GLOW70-0803 | Aug 17, 2026 | 99.80% | 50.66, 10.25, 10.37 mg | <0.05 EU/mL | PDF · COA7598 |
| Humanin | 10 mg | HUM10-0803 | Aug 17, 2026 | 99.79% | 10.60 mg | <0.05 EU/mL | PDF · COA7583 |
| Humanin | 10 mg | HUM10-0713 | Aug 17, 2026 | 99.78% | 10.29 mg | <0.05 EU/mL | PDF · COA7608 |
| IGF-1 LR3 | 1 mg | IGF1-0803 | Aug 17, 2026 | 99.55% | 1.12 mg | <0.05 EU/mL | PDF · COA7588 |
| Ipamorelin | 5 mg | IPA5-0803 | Aug 17, 2026 | 99.78% | 5.17 mg | <0.05 EU/mL | PDF · COA7600 |
| Ipamorelin | 10 mg | IPA10-0803 | Aug 17, 2026 | 99.78% | 10.15 mg | <0.05 EU/mL | PDF · COA7624 |
| Kisspeptin-10 | 10 mg | KISS10-0528 | Jun 17, 2026 | 99.9% | 10.05 mg | <0.05 EU/mL | PDF · COA4862 |
| KLOW blend | 80 mg | KLOW80-0713 | Aug 17, 2026 | 99.81% | 50.71, 10.14, 10.82, 10.77 mg | <0.05 EU/mL | PDF · COA7577 |
| KPV | 10 mg | KPV10-0318 | Aug 17, 2026 | 99.73% | 10.20 mg | <0.05 EU/mL | PDF · COA7614 |
| L-Glutathione | 600 mg | LGLU600-0528 | Jun 17, 2026 | 99.9% | 602.43 mg | <0.05 EU/mL | PDF · COA4841 |
| L-Glutathione | 1500 mg | GLU1500-0803 | Aug 17, 2026 | 99.76% | 1505.41 mg | <0.05 EU/mL | PDF · COA7597 |
| Melanotan-1 | 10 mg | MT110-0318 | Apr 3, 2026 | 99.8% | 10.78 mg | ≤0.05 EU/mL | PDF · COA3394 |
| MOTS-c | 10 mg | MOTS10-0803 | Aug 17, 2026 | 99.84% | 10.62 mg | <0.05 EU/mL | PDF · COA7589 |
| MOTS-c | 40 mg | MOTS40-0803 | Aug 17, 2026 | 99.88% | 40.51 mg | <0.05 EU/mL | PDF · COA7618 |
| NAD+ | 500 mg | NAD500-0803 | Aug 17, 2026 | 99.78% | 503.42 mg | <0.05 EU/mL | PDF · COA7592 |
| NAD+ | 1000 mg | NAD1000-0803 | Aug 17, 2026 | 99.74% | 1004.23 mg | <0.05 EU/mL | PDF · COA7611 |
| P-21 | 5 mg | P21-5-0318 | Jun 17, 2026 | 99.8% | 5.25 mg | <0.05 EU/mL | PDF · COA4866 |
| P-21 | 5 mg | P21-5-0318 | Apr 3, 2026 | 99.6% | 5.42 mg | ≤0.05 EU/mL | PDF · COA3388 |
| PE-22-28 | 10 mg | PE2228-0528 | Jun 17, 2026 | 99.9% | 10.21 mg | <0.05 EU/mL | PDF · COA4859 |
| PEP-RTA-3 | 10 mg | RETA10-0803 | Aug 17, 2026 | 99.83% | 10.61 mg | <0.05 EU/mL | PDF · COA7580 |
| PEP-RTA-3 | 20 mg | RETA20-0803 | Aug 17, 2026 | 99.79% | 20.22 mg | <0.05 EU/mL | PDF · COA7599 |
| PEP-RTA-3 | 30 mg | RETA30-0803 | Aug 17, 2026 | 99.83% | 30.94 mg | <0.05 EU/mL | PDF · COA7619 |
| PEP-RTA-3 | 48 mg | RETA48-0616 | Jun 25, 2026 | 99.9% | 48.16 mg | <0.05 EU/mL | PDF · COA5633 |
| PEP-RTA-3 | 60 mg | RETA60-0803 | Aug 17, 2026 | 99.85% | 61.26 mg | <0.05 EU/mL | PDF · COA7629 |
| PEP-RTA-3 + PEP-CAG-A | 12.5 mg / 2.5 mg | RTCAG15-0803 | Aug 17, 2026 | 99.70% | 12.59,2.61 mg | <0.05 EU/mL | PDF · COA7594 |
| PEP-SMG-1 | 5 mg | SEMA5-0803 | Aug 17, 2026 | 99.75% | 5.19 mg | <0.05 EU/mL | PDF · COA7591 |
| PEP-SMG-1 | 10 mg | SEMA10-0616 | Jun 25, 2026 | 99.9% | 10.52 mg | ≤0.05 EU/mL | PDF · COA5632 |
| PEP-SMG-1 | 20 mg | SEMA20-0528 | Jun 17, 2026 | 99.9% | 20.93 mg | <0.05 EU/mL | PDF · COA4845 |
| PEP-SMG-1 | 30 mg | SEMA30-0803 | Aug 17, 2026 | 99.87% | 30.73 mg | <0.05 EU/mL | PDF · COA7612 |
| PEP-TSM-G | 10 mg | TESA10-0803 | Aug 17, 2026 | 99.79% | 10.18 mg | <0.05 EU/mL | PDF · COA7630 |
| PEP-TSM-G | 20 mg | TESA20-0803 | Aug 17, 2026 | 99.79% | 20.92 mg | <0.05 EU/mL | PDF · COA7605 |
| PEP-TSM-G + Ipamorelin | 10 mg / 5 mg | TESIPA-0803 | Aug 17, 2026 | 99.81% | 10.74, 5.40 mg | <0.05 EU/mL | PDF · COA7626 |
| PEP-TZP-2 | 10 mg | TIR10-0803 | Aug 17, 2026 | 99.80% | 10.18 mg | <0.05 EU/mL | PDF · COA7606 |
| PEP-TZP-2 | 20 mg | TIR20-0803 | Aug 17, 2026 | 99.80% | 20.77 mg | <0.05 EU/mL | PDF · COA7623 |
| PEP-TZP-2 | 30 mg | TIR30-0803 | Aug 17, 2026 | 99.85% | 30.69 mg | <0.05 EU/mL | PDF · COA7617 |
| PEP-TZP-2 | 60 mg | TIR60-0803 | Aug 17, 2026 | 99.79% | 61.11 mg | <0.05 EU/mL | PDF · COA7613 |
| PEP-TZP-2 | 100 mg | TIR100-0803 | Aug 17, 2026 | 99.85% | 101.88 mg | <0.05 EU/mL | PDF · COA7593 |
| Pinealon | 20 mg | PINE20-0803 | Aug 17, 2026 | 99.68% | 20.80 mg | <0.05 EU/mL | PDF · COA7610 |
| Prostamax | 20 mg | PROS20-0318 | Apr 3, 2026 | 99.9% | 12.82 mg | ≤0.05 EU/mL | PDF · COA3398 |
| PT-141 | 10 mg | PT141-0803 | Aug 17, 2026 | 99.85% | 10.24 mg | <0.05 EU/mL | PDF · COA7625 |
| Selank | 10 mg | SEL10-0803 | Aug 17, 2026 | 99.83% | 10.93 mg | <0.05 EU/mL | PDF · COA7627 |
| Selank + Semax | 5 mg / 5 mg | SEMSEL5-0803 | Aug 17, 2026 | 99.76% | 5.15, 5.37 mg | <0.05 EU/mL | PDF · COA7604 |
| Semax | 10 mg | SEMX10-0803 | Aug 17, 2026 | 99.82% | 10.50 mg | <0.05 EU/mL | PDF · COA7586 |
| Sermorelin | 5 mg | SERMO5-0318 | Apr 3, 2026 | 99.8% | 6.36 mg | ≤0.05 EU/mL | PDF · COA3372 |
| SNAP-8 | 10 mg | SN810-0803 | Aug 17, 2026 | 99.75% | 10.47 mg | <0.05 EU/mL | PDF · COA7620 |
| SS-31 | 10 mg | SS31-10-0803 | Aug 17, 2026 | 99.77% | 10.44 mg | <0.05 EU/mL | PDF · COA7584 |
| SS-31 | 30 mg | SS31-30-0803 | Aug 17, 2026 | 99.78% | 30.84 mg | <0.05 EU/mL | PDF · COA7579 |
| SS-31 | 50 mg | SS31-50-0803 | Aug 17, 2026 | 99.75% | 50.90 mg | <0.05 EU/mL | PDF · COA7590 |
| TB-500 | 10 mg | TB10-0803 | Aug 17, 2026 | 99.68% | 10.23 mg | <0.05 EU/mL | PDF · COA7595 |
| Testagen | 20 mg | TESTA20-0528 | Jun 17, 2026 | 99.9% | 20.32 mg | <0.05 EU/mL | PDF · COA4864 |
| Thymalin | 20 mg | THYM20-0318 | Apr 3, 2026 | 99.8% | 18.79 mg | ≤0.05 EU/mL | PDF · COA3390 |
| Thymosin Alpha-1 | 10 mg | TA110-0803 | Aug 17, 2026 | 99.78% | 10.87 mg | <0.05 EU/mL | PDF · COA7585 |
| Vesugen | 20 mg | VESU20-0528 | Jun 17, 2026 | 99.9% | 20.64 mg | <0.05 EU/mL | PDF · COA4865 |
| Vilon | 20 mg | VILON20-0528 | Jun 17, 2026 | 99.9% | 20.13 mg | <0.05 EU/mL | PDF · COA4861 |
| Earlier lots, superseded by the certificates above. Still valid for vials that carry these lot numbers. | |||||||
| AOD-9604 | 5 mg | AOD5-0318 | Apr 3, 2026 | 99.7% | 5.54 mg | ≤0.05 EU/mL | PDF · COA3362 |
| ARA-290 | 16 mg | ARA290-0616 | Jun 25, 2026 | 99.9% | 16.39 mg | <0.05 EU/mL | PDF · COA5630 |
| BPC-157 | 10 mg | BP10-0318 | Apr 3, 2026 | 99.8% | 10.02 mg | ≤0.05 EU/mL | PDF · COA3400 |
| BPC-157 | 5 mg | BP10-0318 | Apr 3, 2026 | 99.7% | 6.42 mg | ≤0.05 EU/mL | PDF · COA3402 |
| BPC-157 + TB-500 | 20 mg | BPCTB20-0616 | Jun 25, 2026 | 99.9% | 10.72, 10.16 mg | <0.05 EU/mL | PDF · COA5623 |
| CJC-1295 + Ipamorelin | 10 mg / 10 mg | CJCIP20-0528 | Jun 17, 2026 | 99.9% | 10.34, 10.46 mg | <0.05 EU/mL | PDF · COA4854 |
| CJC-1295 + Ipamorelin | 5 mg / 5 mg | CJCIP10-0528 | Jun 17, 2026 | 99.9% | 5.77,5.24 mg | <0.05 EU/mL | PDF · COA4855 |
| DSIP | 5 mg | DSIP5-0528 | Jun 17, 2026 | 99.9% | 5.23 mg | <0.05 EU/mL | PDF · COA4853 |
| Epithalon | 10 mg | EPIT10-0528 | Jun 17, 2026 | 99.8% | 10.13 mg | <0.05 EU/mL | PDF · COA4850 |
| GHK-Cu | 100 mg | GHK100-0616 | Jun 25, 2026 | 99.8% | 101.17 mg | <0.05 EU/mL | PDF · COA5624 |
| GHK-Cu | 50 mg | GHK50-0616 | Jun 25, 2026 | 99.9% | 50.67 mg | <0.05 EU/mL | PDF · COA5625 |
| GLOW mix | 70 mg | GLOW70-0318 | Apr 4, 2026 | 99.8% | 51.45, 11.45, 10.87 mg | ≤0.05 EU/mL | PDF · COA3384 |
| IGF-1 LR3 | 1 mg | IGF-0528 | Jun 17, 2026 | 99.9% | 1.21 mg | <0.05 EU/mL | PDF · COA4846 |
| Ipamorelin | 5 mg | IPA5-0318 | Apr 3, 2026 | 99.9% | 5.64 mg | ≤0.05 EU/mL | PDF · COA3380 |
| KLOW blend | 80 mg | KLOW80-0616 | Jun 25, 2026 | 99.9% | 10.27, 50.86, 10.32, 10.49 mg | <0.05 EU/mL | PDF · COA5626 |
| KPV | 10 mg | KPV10-0318 | Apr 3, 2026 | 99.9% | 9.86 mg | ≤0.05 EU/mL | PDF · COA3368 |
| MOTS-c | 10 mg | MOTS10-0318 | Apr 3, 2026 | 99.9% | 11.28 mg | ≤0.05 EU/mL | PDF · COA3396 |
| NAD+ | 1000 mg | NAD1000-0401 | Jun 17, 2026 | 99.9% | 1002.51 mg | <0.05 EU/mL | PDF · COA4843 |
| NAD+ | 500 mg | NAD500-0401 | Jun 17, 2026 | 99.9% | 502.47 mg | <0.05 EU/mL | PDF · COA4842 |
| PEP-RTA-3 | 10 mg | RETA10-0616 | Jun 25, 2026 | 99.8% | 10.49 mg | <0.05 EU/mL | PDF · COA5627 |
| PEP-RTA-3 | 20 mg | RETA20-0616 | Jun 25, 2026 | 99.9% | 20.58 mg | <0.05 EU/mL | PDF · COA5628 |
| PEP-RTA-3 | 30 mg | RT30-0528 | Jun 17, 2026 | 99.9% | 30.84 mg | <0.05 EU/mL | PDF · COA4858 |
| PEP-RTA-3 | 60 mg | RT60-0528 | Jun 17, 2026 | 99.9% | 60.79 mg | <0.05 EU/mL | PDF · COA4857 |
| PEP-RTA-3 + PEP-CAG-A | 12.5 mg / 2.5 mg | RTCAG15-0616 | Jun 25, 2026 | 99.9% | 12.59, 2.68 mg | <0.05 EU/mL | PDF · COA5635 |
| PEP-TSM-G | 10 mg | TESA10-0528 | Jun 17, 2026 | 99.9% | 10.66 mg | <0.05 EU/mL | PDF · COA4849 |
| PEP-TSM-G | 20 mg | TESA20-0528 | Jun 17, 2026 | 99.9% | 20.72 mg | <0.05 EU/mL | PDF · COA4848 |
| PEP-TSM-G | 10 mg | TESA10-0318 | Apr 3, 2026 | 99.8% | 11.71 mg | ≤0.05 EU/mL | PDF · COA3376 |
| PEP-TSM-G + Ipamorelin | 10 mg / 5 mg | TESAIPA-0616 | Jun 25, 2026 | 99.9% | 5.31,10.54 mg | <0.05 EU/mL | PDF · COA5631 |
| PEP-TZP-2 | 100 mg | TIR100-0616 | Jun 25, 2026 | 99.9% | 101.25 mg | <0.05 EU/mL | PDF · COA5634 |
| PEP-TZP-2 | 10 mg | TIR10-0528 | Jun 17, 2026 | 99.9% | 10.42 mg | <0.05 EU/mL | PDF · COA4851 |
| PEP-TZP-2 | 20 mg | TIR20-0528 | Jun 17, 2026 | 99.9% | 20.38 mg | <0.05 EU/mL | PDF · COA4856 |
| PEP-TZP-2 | 60 mg | TIR600-0528 | Jun 17, 2026 | 99.9% | 60.57 mg | <0.05 EU/mL | PDF · COA4852 |
| PEP-TZP-2 | 10 mg | TIRZ10-0318 | Apr 3, 2026 | 99.8% | 11.06 mg | ≤0.05 EU/mL | PDF · COA3366 |
| Pinealon | 20 mg | PINE20-0318 | Apr 3, 2026 | 99.8% | 19.12 mg | ≤0.05 EU/mL | PDF · COA3386 |
| PT-141 | 10 mg | PT141-0528 | Jun 17, 2026 | 99.9% | 10.13 mg | <0.05 EU/mL | PDF · COA4863 |
| Selank | 10 mg | SEL10-0528 | Jun 17, 2026 | 99.8% | 10.56 mg | <0.05 EU/mL | PDF · COA4847 |
| Selank | 10 mg | SEL10-0318 | Apr 3, 2026 | 99.6% | 10.72 mg | ≤0.05 EU/mL | PDF · COA3382 |
| Selank + Semax dissolving strips | 5 mg / 5 mg | SEMSEL5-0616 | Jun 25, 2026 | 99.9% | 5.22,5.39 mg | <0.05 EU/mL | PDF · COA5629 |
| Semax | 10 mg | SEMX10-0528 | Jun 17, 2026 | 99.9% | 10.68 mg | <0.05 EU/mL | PDF · COA4844 |
| Semax | 10 mg | SEMX10-0318 | Apr 3, 2026 | 99.8% | 11.26 mg | ≤0.05 EU/mL | PDF · COA3374 |
| SS-31 | 10 mg | SS31-10-0318 | Apr 3, 2026 | 99.7% | 9.76 mg | ≤0.05 EU/mL | PDF · COA3370 |
| TB-500 | 10 mg | TB10-0318 | Apr 3, 2026 | 99.8% | 12.12 mg | ≤0.05 EU/mL | PDF · COA3404 |
| Thymosin Alpha-1 | 10 mg | TA110-0318 | Apr 3, 2026 | 99.8% | 10.76 mg | ≤0.05 EU/mL | PDF · COA3362 |
Certificates are published exactly as issued by the laboratory. Purity is reported by RP-HPLC at 214 nm, identity by LC-MS/MS or MALDI-MS, content by HPLC quantitation; endotoxin, heavy metals and sterility follow the USP chapter printed beside each result.
What should a COA show?
A certificate worth trusting names the laboratory, the method, the lot, and the date. It reports purity as a percentage from an HPLC trace, identity as a measured mass against the expected mass, content in milligrams, and endotoxin against a stated threshold. If any of those four are missing, ask why.
Read the full guide
Every month's certificates, summarised
One report per month the laboratory issued certificates in: what was tested, by which method, and what changed.
- Lot report: August 2026 · 54 certificates
- Lot report: June 2026 · 39 certificates
- Lot report: April 2026 · 21 certificates
